SCHEMBL6537693

SCHEMBL6537693

C=CCc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
SLC16A3 O15427 1/20 0.42
JAK2 O60674 4/20 0.41
TYK2 P29597 4/20 0.41
JAK1 P23458 2/20 0.41
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
CRHBP P24387 1/20 0.38
HTT P42858 1/20 0.38
CRHR2 Q13324 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CDK14 O94921 3/20 0.38
CCNY Q8ND76 3/20 0.38
MAPK10 P53779 2/20 0.38
MAPK8 P45983 1/20 0.38
CYP3A4 P08684 1/20 0.38
KDR P35968 1/20 0.37
PABPC1 P11940 1/20 0.37
EIF4H Q15056 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538034 0.87 TYK2 (0.45) SLC16A3JAK2TYK2JAK1KMT2A
SCHEMBL6537957 0.85 TYK2 (0.44) SLC16A3JAK2TYK2JAK1KMT2A
SCHEMBL6537843 0.83 SLC16A3 (0.42) SLC16A3JAK2TYK2JAK1KMT2A
SCHEMBL6537695 0.82 PTGES (0.44) ALDH1A1SLC16A3JAK2TYK2JAK1
SCHEMBL6537920 0.82 TYK2 (0.41) SLC16A3JAK2TYK2JAK1KMT2A
SCHEMBL6538065 0.81 GAA (0.42) ALDH1A1SLC16A3JAK2TYK2JAK1
SCHEMBL6537997 0.80 TYK2 (0.42) ALDH1A1HPGDSLC16A3JAK2TYK2
SCHEMBL6537732 0.80 TYK2 (0.42) SLC16A3JAK2TYK2JAK1KMT2A
SCHEMBL6537962 0.79 TYK2 (0.46) SLC16A3JAK2TYK2JAK1KMT2A
SCHEMBL6537674 0.79 TYK2 (0.46) ALDH1A1JAK2TYK2JAK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed